Jasper Therapeutics, Inc. (JSPRW) — 10-Q Filings

10-Q Filings (6)

• Jasper Therapeutics' Losses Mount, Cash Dwindles Amid R&D Surge — Nov 10, 2025 Risk: high
  Jasper Therapeutics, Inc. (JSPRW) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $66.7 million, up from $46.
• Jasper Therapeutics' Losses Mount, Cash Dwindles Amid R&D Surge — Aug 13, 2025 Risk: high
  Jasper Therapeutics, Inc. (JSPRW) reported a significant increase in net losses and operating expenses for the three and six months ended June 30, 2025. The net
• Jasper Therapeutics Files Q1 2025 10-Q — May 12, 2025 Risk: low
  Jasper Therapeutics, Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, formerly known as Amplitude Healthcare Acquisition Corp, is
• Jasper Therapeutics Files Q3 2024 10-Q — Nov 7, 2024 Risk: low
  Jasper Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, formerly known as Amplitude Healthcare A
• Jasper Therapeutics Files Q2 2024 10-Q — Aug 13, 2024 Risk: low
  Jasper Therapeutics, Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as Amplitude Healthcare Acquisition Corp, is
• Jasper Therapeutics, Inc. Files 10-Q for Period Ended March 31, 2024 — May 14, 2024 Risk: low
  Jasper Therapeutics, Inc. (JSPRW) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Jasper Therapeutics, Inc. filed a 10-Q report for the quarterly

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX